R&D channel feed – Endpoints News

R&D channel feed

Amgen reports dual Phase 3 wins in atopic dermatitis and myasthenia gravis

8 months ago

Wave rides new Phase 2 DMD data as it sets sights on accelerated approval

8 months ago

Clive Meanwell's new obesity biotech, Metsera, unveils early GLP-1 data with an eye on Phase 3 next year

8 months ago

Exclusive: Constructive Bio raises $58M for synbio work, and Nobel laureate joins board

8 months ago

Biogen, UCB declare Phase 3 lupus win and prep a second trial, but details are scant

8 months ago

Corrected: Over a year after FDA rejection, Biohaven claims success in pivotal neurodegenerative disease study

8 months ago

Black Diamond treads water on small snapshot of Phase 2 lung cancer data

8 months ago

Q&A: Bristol Myers’ tech chief on the promises and perils of AI bio

8 months ago

Ideaya outlines regulatory path for rare eye cancer drug after positive mid-stage data

8 months ago

AstraZeneca, Daiichi’s TROP2 drug misses overall survival goal in Phase 3 breast cancer trial

8 months ago

Regulatory RNA startup CAMP4 files for IPO as more biotechs line up listings

8 months ago

Novo says its CB1 drug helped shed weight, but efficacy and safety questions remain

8 months ago

Novo axes Phase 2 of Forma-acquired drug in myelodysplastic syndromes

8 months ago

Sanofi's BTK inhibitor again slows MS progression, but liver enzymes continue to be tricky

8 months ago

Aligos’ trial for oral MASH treatment succeeds, but placebo group shows odd trend

8 months ago

Edgewise’s stock surges as heart drug passes early safety test

8 months ago

4DMT's gene therapy reduced need for standard-of-care injections to treat age-associated vision loss

8 months ago

Keytruda adds new FDA approval for a rare form of mesothelioma

8 months ago

With few efficacy details, Insilico claims a Phase 2a win in latest AI readout

8 months ago

You bet your life: After I was diagnosed with a rare cancer, I discovered how a small band of physician-scientists triggered a revolution

8 months ago

Conducting trials via routine clinical practice: FDA explains how in new draft guidance

8 months ago

Sun, surprises and new summits at Europe’s biggest cancer conference

8 months ago

After landing a key win in a common cancer condition, Pfizer faces a big test in Phase 3

8 months ago

Merck and Daiichi’s rejected HER3 ADC clears a Phase 3 in certain lung cancers

8 months ago

First page Previous page 25 26 272829 30 31 Next page Last page